We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
Cap. Flow
+$2.19B
Cap. Flow %
3.26%
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$146M
2
AAPL icon
Apple
AAPL
+$75.7M
3
TSLA icon
Tesla
TSLA
+$70.4M
4
AMZN icon
Amazon
AMZN
+$65M
5
PG icon
Procter & Gamble
PG
+$55.9M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Healthcare 14.42%
3 Financials 13.62%
4 Consumer Discretionary 11.36%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRGY icon
2451
Crescent Energy
CRGY
$3.82B
$550K ﹤0.01%
40,811
+2,733
+7% +$40K
WKHS icon
2452
Workhorse Group
WKHS
$36.3M
$550K ﹤0.01%
64
+7
+12% +$68K
ONTF
2453
DELISTED
ON24
ONTF
$549K ﹤0.01%
62,330
+3,417
+6% +$32.7K
PTLO icon
2454
Portillo's
PTLO
$321M
$548K ﹤0.01%
27,853
+5,385
+24% +$119K
RBCAA icon
2455
Republic Bancorp
RBCAA
$1.95B
$548K ﹤0.01%
14,311
+733
+5% +$32.5K
CDRE icon
2456
Cadre Holdings
CDRE
$1.41B
$547K ﹤0.01%
22,743
+4,167
+22% +$102K
SPWH icon
2457
Sportsman's Warehouse
SPWH
$46M
$547K ﹤0.01%
65,917
+3,821
+6% +$36.2K
KNTE
2458
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$547K ﹤0.01%
45,773
+2,816
+7% +$36.9K
HRTX icon
2459
Heron Therapeutics
HRTX
$92.9M
$545K ﹤0.01%
129,259
+8,472
+7% +$33.2K
KPTI icon
2460
Karyopharm Therapeutics
KPTI
$48M
$545K ﹤0.01%
6,649
+554
+9% +$41.4K
IBRX icon
2461
ImmunityBio
IBRX
$8.1B
$544K ﹤0.01%
109,527
+8,495
+8% +$38.7K
KALV
2462
DELISTED
KalVista Pharmaceuticals
KALV
$544K ﹤0.01%
37,513
+2,844
+8% +$39.8K
CSV icon
2463
Carriage Services
CSV
$569M
$542K ﹤0.01%
16,850
+1,094
+7% +$40.9K
HIFS icon
2464
Hingham Institution for Saving
HIFS
$663M
$541K ﹤0.01%
2,153
+124
+6% +$36.3K
IIIV icon
2465
i3 Verticals
IIIV
$342M
$541K ﹤0.01%
26,992
+2,340
+9% +$57K
LOCO icon
2466
El Pollo Loco
LOCO
$462M
$541K ﹤0.01%
60,655
+2,829
+5% +$26.6K
VCTR icon
2467
Victory Capital Holdings
VCTR
$6.65B
$540K ﹤0.01%
23,171
+1,348
+6% +$35.8K
ATRA icon
2468
Atara Biotherapeutics
ATRA
$76.1M
$536K ﹤0.01%
5,668
+101
+2% +$11.3K
BV icon
2469
BrightView Holdings
BV
$1.07B
$535K ﹤0.01%
67,438
+3,659
+6% +$39.1K
DH icon
2470
Definitive Healthcare
DH
$75.3M
$533K ﹤0.01%
34,307
+6,584
+24% +$145K
BLX icon
2471
Bladex Inc
BLX
$2.14B
$531K ﹤0.01%
40,640
+2,223
+6% +$31.4K
CMPR icon
2472
Cimpress
CMPR
$2.31B
$529K ﹤0.01%
21,600
+1,451
+7% +$49.6K
IMGO
2473
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$527K ﹤0.01%
35,033
+2,278
+7% +$37K
IEA
2474
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$527K ﹤0.01%
38,958
+3,451
+10% +$44.8K
BHR
2475
Braemar Hotels & Resorts
BHR
$142M
$525K ﹤0.01%
121,977
+6,811
+6% +$34.5K

Similar funds

RhumbLine Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.

  • RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
  • RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
  • RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
  • RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
  • RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
  • RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.

Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.